1
|
Tamaki K, Morishima S, Nomura S, Nishi Y, Nakachi S, Kitamura S, Uchibori S, Tomori S, Hanashiro T, Shimabukuro N, Tedokon I, Morichika K, Taira N, Tomoyose T, Miyagi T, Karimata K, Ohama M, Yamanoha A, Tamaki K, Hayashi M, Uchihara J, Ohshiro K, Asakura Y, Kuba‐Miyara M, Karube K, Fukushima T, Masuzaki H. Evaluation of two prognostic indices for adult T-cell leukemia/lymphoma in the subtropical endemic area, Okinawa, Japan. Cancer Sci 2018; 109:2286-2293. [PMID: 29772611 PMCID: PMC6029833 DOI: 10.1111/cas.13641] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2018] [Revised: 05/07/2018] [Accepted: 05/08/2018] [Indexed: 11/28/2022] Open
Abstract
Aggressive adult T-cell leukemia/lymphoma (ATL) has an extremely poor prognosis and is hyperendemic in Okinawa, Japan. This study evaluated two prognostic indices (PIs) for aggressive ATL, the ATL-PI and Japan Clinical Oncology Group (JCOG)-PI, in a cohort from Okinawa. The PIs were originally developed using two different Japanese cohorts that included few patients from Okinawa. The endpoint was overall survival (OS). Multivariable Cox regression analyses in the cohort of 433 patients revealed that all seven factors for calculating each PI were statistically significant prognostic predictors. Three-year OS rates for ATL-PI were 35.9% (low-risk, n = 66), 10.4% (intermediate-risk, n = 256), and 1.6% (high-risk, n = 111), and those for JCOG-PI were 22.4% (moderate-risk, n = 176) and 5.3% (high-risk, n = 257). The JCOG-PI moderate-risk group included both the ATL-PI low- and intermediate-risk groups. ATL-PI more clearly identified the low-risk patient subgroup than JCOG-PI. To evaluate the external validity of the two PIs, we also assessed prognostic discriminability among 159 patients who loosely met the eligibility criteria of a previous clinical trial. Three-year OS rates for ATL-PI were 34.5% (low-risk, n = 42), 9.2% (intermediate-risk, n = 109), and 12.5% (high-risk, n = 8). Those for JCOG-PI were 22.4% (moderate-risk, n = 95) and 7.6% (high-risk, n = 64). The low-risk ATL-PI group had a better prognosis than the JCOG-PI moderate-risk group, suggesting that ATL-PI would be more useful than JCOG-PI for establishing and examining novel treatment strategies for ATL patients with a better prognosis. In addition, strongyloidiasis, previously suggested to be associated with ATL-related deaths in Okinawa, was not a prognostic factor in this study.
Collapse
Affiliation(s)
- Keita Tamaki
- Division of Endocrinology, Diabetes and Metabolism, Hematology and RheumatologySecond Department of Internal MedicineGraduate School of MedicineUniversity of the RyukyusNishiharaJapan
| | - Satoko Morishima
- Division of Endocrinology, Diabetes and Metabolism, Hematology and RheumatologySecond Department of Internal MedicineGraduate School of MedicineUniversity of the RyukyusNishiharaJapan
| | - Shogo Nomura
- Clinical Research Support OfficeNational Cancer Center Hospital EastKashiwaJapan
| | - Yukiko Nishi
- Division of Endocrinology, Diabetes and Metabolism, Hematology and RheumatologySecond Department of Internal MedicineGraduate School of MedicineUniversity of the RyukyusNishiharaJapan
| | - Sawako Nakachi
- Division of Endocrinology, Diabetes and Metabolism, Hematology and RheumatologySecond Department of Internal MedicineGraduate School of MedicineUniversity of the RyukyusNishiharaJapan
| | - Sakiko Kitamura
- Division of Endocrinology, Diabetes and Metabolism, Hematology and RheumatologySecond Department of Internal MedicineGraduate School of MedicineUniversity of the RyukyusNishiharaJapan
| | - Sachie Uchibori
- Division of Endocrinology, Diabetes and Metabolism, Hematology and RheumatologySecond Department of Internal MedicineGraduate School of MedicineUniversity of the RyukyusNishiharaJapan
| | - Shouhei Tomori
- Division of Endocrinology, Diabetes and Metabolism, Hematology and RheumatologySecond Department of Internal MedicineGraduate School of MedicineUniversity of the RyukyusNishiharaJapan
| | - Taeko Hanashiro
- Division of Endocrinology, Diabetes and Metabolism, Hematology and RheumatologySecond Department of Internal MedicineGraduate School of MedicineUniversity of the RyukyusNishiharaJapan
| | - Natsuki Shimabukuro
- Division of Endocrinology, Diabetes and Metabolism, Hematology and RheumatologySecond Department of Internal MedicineGraduate School of MedicineUniversity of the RyukyusNishiharaJapan
| | - Iori Tedokon
- Division of Endocrinology, Diabetes and Metabolism, Hematology and RheumatologySecond Department of Internal MedicineGraduate School of MedicineUniversity of the RyukyusNishiharaJapan
| | - Kazuho Morichika
- Division of Endocrinology, Diabetes and Metabolism, Hematology and RheumatologySecond Department of Internal MedicineGraduate School of MedicineUniversity of the RyukyusNishiharaJapan
| | - Naoya Taira
- Department of HematologyHeartlife HospitalNakagusukuJapan
| | | | - Takashi Miyagi
- Department of HematologyHeartlife HospitalNakagusukuJapan
| | - Kaori Karimata
- Department of HematologyHeartlife HospitalNakagusukuJapan
| | - Masayo Ohama
- Department of HematologyHeartlife HospitalNakagusukuJapan
| | | | - Kazumitsu Tamaki
- Department of HematologyOkinawa Prefectural Chubu HospitalUrumaJapan
| | | | | | - Kazuiku Ohshiro
- Department of HematologyOkinawa Prefectural Nambu Medical Center and Children's Medical CenterHaebaruJapan
| | | | - Megumi Kuba‐Miyara
- Laboratory of HematoimmunologySchool of Health SciencesFaculty of MedicineUniversity of the RyukyusNishiharaJapan
| | - Kennosuke Karube
- Departments of Pathology and Cell BiologyGraduate School of MedicineUniversity of the RyukyusNishiharaJapan
| | - Takuya Fukushima
- Laboratory of HematoimmunologySchool of Health SciencesFaculty of MedicineUniversity of the RyukyusNishiharaJapan
| | - Hiroaki Masuzaki
- Division of Endocrinology, Diabetes and Metabolism, Hematology and RheumatologySecond Department of Internal MedicineGraduate School of MedicineUniversity of the RyukyusNishiharaJapan
| |
Collapse
|
2
|
Tamaki K, Morishima S, Nomura S, Tomoyose T, Nakachi S, Nishi Y, Taira N, Miyagi T, Karimata K, Ohama M, Yamanoha A, Tamaki K, Hayashi M, Uchihara JN, Ohshiro K, Asakura Y, Kuba-Miyara M, Karube K, Fukushima T, Masuzaki H. External validation of prognostic indices for aggressive adult T-cell leukemia/lymphoma (ATL-PI/JCOG-PI) in Okinawa. J Clin Oncol 2017. [DOI: 10.1200/jco.2017.35.15_suppl.e19036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e19036 Background: Aggressive adult T-cell leukemia/lymphoma (aATL) has an extremely poor prognosis (median OS, 8-10 months). Okinawa, Japan’s only subtropical region, is hyperendemic for aATL. Recently, we demonstrated poorer outcomes among aATL patients in Okinawa compared with patients elsewhere in Japan, and a possible association of strongyloidiasis with ATL-related death. Two prognostic indices (PIs)—ATL-PI and JCOG-PI—have been developed using a database of national surveys and clinical trials. However, aATL patients in Okinawa were not included. This study aimed to validate these PIs using an Okinawa database. We also investigated the impact of strongyloidiasis on aATL patient survival. Methods: We constructed a clinical database of aATL patients from 7 institutions in Okinawa diagnosed between January 2002 and December 2011. The study endpoint was OS. Standard survival analysis methods (Kaplan-Meier method, log-rank test, and Cox proportional-hazards model) were used. Results: The study involved 433 evaluable patients (median OS, 6 months). Risks according to the two PIs in each patient were not always consistent (Table), but both PIs stratified aATL patients by risk. Three-year OS rates for ATL-PI were 35.9% (low-risk, n=66), 10.4% (intermediate-risk, n=256), and 1.6% (high-risk, n=111); rates for JCOG-PI were 22.4% (moderate-risk, n=176) and 5.3% (high-risk, n=257). Strongyloidiasis had little impact on OS (HR and 95% CI from univariate Cox analysis, 1.22 and 0.90-1.66, respectively). Multivariable Cox analysis returned almost the same factors as had been screened out in the previous studies to construct the two PIs. Conclusions: ATL-PI and JCOG-PI were well reproducible in Okinawa database. Strongyloidiasis did not affect prognosis in aATL patients. ATL-PI identifies low-risk aATL patients more clearly than JCOG-PI, and both identify high-risk patients with extremely poor prognosis. These will be useful to devise novel treatment strategies based on risk stratification of all Japan/world aATL patients. [Table: see text]
Collapse
Affiliation(s)
- Keita Tamaki
- Division of Endocrinology, Diabetes and Metabolism, Hematology and Rheumatology (Second Department of Medicine), Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan
| | - Satoko Morishima
- Division of Endocrinology, Diabetes and Metabolism, Hematology and Rheumatology (Second Department of Medicine), Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan
| | - Shogo Nomura
- Clinical Research Support Office, National Cancer Center Hospital East, Chiba, Japan
| | - Takeaki Tomoyose
- Division of Endocrinology, Diabetes and Metabolism, Hematology and Rheumatology (Second Department of Medicine), Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan
| | - Sawako Nakachi
- Division of Endocrinology, Diabetes and Metabolism, Hematology and Rheumatology (Second Department of Medicine), Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan
| | - Yukiko Nishi
- Division of Endocrinology, Diabetes and Metabolism, Hematology and Rheumatology (Second Department of Medicine), Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan
| | - Naoya Taira
- Department of Hematology, Heartlife Hospital, Okinawa, Japan
| | - Takashi Miyagi
- Department of Hematology, Heartlife Hospital, Okinawa, Japan
| | - Kaori Karimata
- Department of Hematology, Heartlife Hospital, Okinawa, Japan
| | - Masayo Ohama
- Department of Hematology, Heartlife Hospital, Okinawa, Japan
| | | | - Kazumitsu Tamaki
- Department of Hematology, Okinawa Prefectural Chubu Hospital, Okinawa, Japan
| | - Masaki Hayashi
- Department of Hematology, Nakagami Hospital, Okinawa, Japan
| | | | - Kazuiku Ohshiro
- Department of Hematology, Okinawa Prefectural Nambu Medical Center and Children’s Medical Center, Okinawa, Japan
| | - Yoshitaka Asakura
- Department of Hematology, Okinawa Red Cross Hospital, Okinawa, Japan
| | - Megumi Kuba-Miyara
- Laboratory of Hematoimmunology, School of Health Sciences, Faculty of Medicine, University of the Ryukyus, Nishihara, Japan
| | - Kennosuke Karube
- Departments of Pathology and Cell Biology, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan
| | - Takuya Fukushima
- Laboratory of Hematoimmunology, School of Health Sciences, Faculty of Medicine, University of the Ryukyus, Nishihara, Japan
| | - Hiroaki Masuzaki
- Division of Endocrinology, Diabetes and Metabolism, Hematology and Rheumatology (Second Department of Medicine), Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan
| |
Collapse
|
3
|
Nishi Y, Fukushima T, Nomura S, Tomoyose T, Nakachi S, Morichika K, Tedokon I, Tamaki K, Shimabukuro N, Taira N, Miyagi T, Karimata K, Ohama M, Yamanoha A, Tamaki K, Hayashi M, Arakaki H, Uchihara JN, Ohshiro K, Asakura Y, Kuba-Miyara M, Karube K, Masuzaki H. Characterization of patients with aggressive adult T-cell leukemia–lymphoma in Okinawa, Japan: a retrospective analysis of a large cohort. Int J Hematol 2016; 104:468-75. [DOI: 10.1007/s12185-016-2042-y] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2016] [Revised: 06/15/2016] [Accepted: 06/15/2016] [Indexed: 10/21/2022]
|
4
|
Miyagi T, Itonaga H, Aosai F, Taguchi J, Norose K, Mochizuki K, Fujii H, Furumoto A, Ohama M, Karimata K, Yamanoha A, Taniguchi H, Sato S, Taira N, Moriuchi Y, Fukushima T, Masuzaki H, Miyazaki Y. Successful treatment of toxoplasmic encephalitis diagnosed early by polymerase chain reaction after allogeneic hematopoietic stem cell transplantation: two case reports and review of the literature. Transpl Infect Dis 2015; 17:593-8. [PMID: 25970830 DOI: 10.1111/tid.12401] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2015] [Revised: 03/31/2015] [Accepted: 04/17/2015] [Indexed: 11/26/2022]
Abstract
Toxoplasmic encephalitis represents a rare, but often fatal infection after allogeneic hematopoietic stem cell transplantation. Polymerase chain reaction (PCR)-based preemptive therapy is considered promising for this disease, but is not routinely applied, especially in low seroprevalence countries including Japan. We encountered 2 cases of toxoplasmic encephalitis after transplantation that were successfully treated. The diagnosis of toxoplasmic encephalitis in these cases was confirmed by PCR testing when neurological symptoms were observed. Both patients received pyrimethamine and sulfadiazine treatments within 2 weeks of the development of neurological symptoms, and remained free of recurrence for 32 and 12 months. These results emphasized the importance of the PCR test and immediate treatment after diagnosis for the management of toxoplasmic encephalitis.
Collapse
Affiliation(s)
- T Miyagi
- Department of Hematology, Heartlife Hospital, Okinawa, Japan
| | - H Itonaga
- Department of Hematology, Sasebo City General Hospital, Sasebo, Japan
| | - F Aosai
- Department of Infection and Host Defense, Graduate School of Medicine, Chiba University, Chiba, Japan.,Department of Infection and Host Defense, Graduate School of Medicine, Shinshu University, Matsumoto, Japan
| | - J Taguchi
- Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki City, Japan
| | - K Norose
- Department of Infection and Host Defense, Graduate School of Medicine, Chiba University, Chiba, Japan
| | - K Mochizuki
- Department of Infectious Disease, Nagasaki University Hospital, Nagasaki, Japan
| | - H Fujii
- Department of Infectious Disease, Nagasaki University Hospital, Nagasaki, Japan
| | - A Furumoto
- Department of Infectious Disease, Nagasaki University Hospital, Nagasaki, Japan
| | - M Ohama
- Department of Hematology, Heartlife Hospital, Okinawa, Japan
| | - K Karimata
- Department of Hematology, Heartlife Hospital, Okinawa, Japan
| | - A Yamanoha
- Department of Hematology, Heartlife Hospital, Okinawa, Japan
| | - H Taniguchi
- Department of Hematology, Sasebo City General Hospital, Sasebo, Japan
| | - S Sato
- Department of Hematology, Sasebo City General Hospital, Sasebo, Japan
| | - N Taira
- Department of Hematology, Heartlife Hospital, Okinawa, Japan
| | - Y Moriuchi
- Department of Hematology, Sasebo City General Hospital, Sasebo, Japan
| | - T Fukushima
- Laboratory of Hematoimmunology, Department of Clinical Laboratory Sciences, School of Health Sciences, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan
| | - H Masuzaki
- Division of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology (Second Department of Medicine), Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan
| | - Y Miyazaki
- Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki City, Japan
| |
Collapse
|
5
|
Tomoyose T, Ohama M, Yamanoha A, Masuzaki H, Okudaira T, Tokumine J. Real-time ultrasound-guided central venous catheterization reduces the need for prophylactic platelet transfusion in thrombocytopenic patients with hematological malignancy. Transfus Apher Sci 2013; 49:367-9. [PMID: 23083962 DOI: 10.1016/j.transci.2012.09.005] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2012] [Accepted: 09/18/2012] [Indexed: 02/05/2023]
Affiliation(s)
- Takeaki Tomoyose
- Second Department of Internal Medicine, Graduate School of Medicine, University of the Ryukyus, 207, Uehara, Nishihara, Okinawa 903-0215, Japan.
| | | | | | | | | | | |
Collapse
|
6
|
Matsuo T, Maekawa T, Inaba A, Yamamuro O, Ohama M, Ichikawa M, Tsuchida T. Isotope-dependent crystalline phases at ambient temperature: Spectroscopic and calorimetric evidence for a deuteration-induced phase transition at 320K in α-DCrO2. J Mol Struct 2006. [DOI: 10.1016/j.molstruc.2005.11.038] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
7
|
Suemura N, Ohama M, Kaizaki S. Direct observation of light induced spin transitions in new 3,5-bis(2-pyridyl)pyrazolato bridged thiocyanato diiron(II) complexes by monitoring variable temperature laser Raman spectra. Chem Commun (Camb) 2001:1538-9. [PMID: 12240370 DOI: 10.1039/b104121p] [Citation(s) in RCA: 51] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The light induced excited spin state trapping LIESST and the reverse LIESST-like phenomena are observed below and above the spin transition temperature, respectively, for new dinuclear diiron(II) complexes and familiar Fe(II) complexes with thiocyanate ligands by monitoring the Raman spectra where only excitation light of various wavelengths for the spectroscopy was used without extra excitation light sources.
Collapse
Affiliation(s)
- N Suemura
- Department of Chemistry, Graduate School of Science, Osaka University, Toyonaka, Osaka, 560-0043, Japan
| | | | | |
Collapse
|
8
|
Matsumoto S, Fujiwara T, Ohama M, Ikushima AJ. Crystallization of GeO(2)-SiO(2) glass by poling with ArF-laser excitation. Opt Lett 1999; 24:1404-1406. [PMID: 18079816 DOI: 10.1364/ol.24.001404] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
We report on crystallization of 15.7GeO(2) 84.3SiO(2) (in mol.%) glass by poling with ArF-laser excitation. The UV intensity was 100(mJ/cm (2))/pulse , and the number of shots was 10(4) . The crystallites that were observed in the glass were approximately 15-20microm in diameter. The crystallization feature was dependent on the poling electric field, showing a threshold field of ~0.5x10(5)V/cm , beyond which crystallization occurred.
Collapse
|
9
|
Shingu H, Kimura I, Nasu Y, Shiotani A, Ohama M, Murata M, Fukuda F, Kayaoka M. [Injuries of the spine and the spinal cord in sports]. Nihon Seikeigeka Gakkai Zasshi 1996; 70:353-365. [PMID: 8797198] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Affiliation(s)
- H Shingu
- Department of Orthopaedic Surgery, San-in Rosai Hospital
| | | | | | | | | | | | | | | |
Collapse
|
10
|
Shingu H, Ohama M, Ikata T, Katoh S, Akatsu T. A nationwide epidemiological survey of spinal cord injuries in Japan from January 1990 to December 1992. Paraplegia 1995; 33:183-8. [PMID: 7609973 DOI: 10.1038/sc.1995.42] [Citation(s) in RCA: 61] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
This survey of traumatic spinal cord injuries in Japan from January 1990 to December 1992 was carried out by a statistical method of the nationwide epidemiological study. The number of the registered patients during these 3 years was 9752 and the mean response rate of every of the 47 prefectures was 51.4%. The registered patients with neurological deficits (Frankel A-D) were 7471 and the annual spinal cord injury incidence was 40.2 per million. The ratio of cervical cord injuries to more caudal SCI was 3:1. The age distribution and the causes of spinal cord injuries are presented in detail. From the results of this study, the prevention campaign should be focused mainly on the following topics: sports and motorcycle accidents involving young people; traffic accidents involving adults; falling accidents involving aged people.
Collapse
Affiliation(s)
- H Shingu
- Prevention Committee of Japan Medical Society of Paraplegia, Department of Orthopaedic Surgery, San-in Rosai Hospital, Yonago
| | | | | | | | | |
Collapse
|
11
|
Tsunoda A, Yamada R, Ohama M. [Esophageal atresia: management and postoperative gastroesophageal reflux]. Rinsho Kyobu Geka 1981; 1:181-188. [PMID: 7052588] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
|